Skip to content

Study of dexmedetomidine for perioperative airway management in otorhinolaryngologic surgery

Study of dexmedetomidine for perioperative airway management in otorhinolaryngologic surgery

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091475
Enrollment
Unknown
Registered
2024-10-29
Start date
2020-01-20
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

difficult airway

Interventions

Group D1:0.5ug/kg dexmedetomidine pumped in 10min
Group D2:0.75ug/kg dexmedetomidine pumped in 10min
Group D3:1ug/kg dexmedetomidine pumped in 10min

Sponsors

Eye, Ear, Nose and Throat Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with laryngeal masses whose preoperative airway assessment was a difficult airway and who required transfibrillar guided awake tracheal intubation.

Exclusion criteria

Exclusion criteria: 1) ASA =III; 2) Age <18 years old; 3) history of severe cardiopulmonary disease, central nervous system disease, mental illness, severe liver or kidney disease, or pregnancy; 4) long-term use of sedatives and a history of allergy to such drugs; 5) difficulty in cooperating and inability to cooperate with awake intubation; 6) heart rate <50 beats / minute, or systolic blood pressure <90mmHg.

Design outcomes

Primary

MeasureTime frame
cough score;Tolerance after intubaion;Intubating condition;

Secondary

MeasureTime frame
ETCO2 after intubation;Intubation time;Intubation success rate;satisfaction rating;memory score;

Countries

China

Contacts

Public ContactJia Ji‘e

Eye, Ear, Nose and Throat Hospital of Fudan University

jiajie@eentanesthesia.com+86 189 1778 5693

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026